Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × spartalizumab × Clear all

Phase

Phase 1 23 Phase 1/2 15 Phase 2 14 Phase NA 3 Phase EARLY_PHASE1 1

Status

Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 22 Metformin 14 pembrolizumab 12 Radiotherapy 11 Biopsy 11 Nivolumab 9 Fluorouracil 9 Cyclophosphamide 9 Radiation 7 Bevacizumab 7 gallium 68 PSMA-11 6 Temozolomide 6 Sirolimus 6 Rituximab 6 Letrozole 6 Etoposide 6 Cisplatin 6 Aspirin 6 Surveys and Questionnaires 5 Oxaliplatin 5 Irinotecan 5 Indocyanine Green 5 Granulocyte Colony-Stimulating Factor 5 Fluorodeoxyglucose F18 5 olaparib 4 aldesleukin 4 Surgical Procedures, Operative 4 Radiosurgery 4 Proflavine 4 Methotrexate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04028245 2026-04-15

SPARC-1

Columbia University

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡